Aalto-Setala, T., Marttunen, M., Ruulio-Henriksson, A., Poikolainen, K., and Lonnqvist, J. (2002). Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. Am. J. Psychiatry, 159, 1235–7.Google Scholar

Aarsland, D., Larsen, J. P., Waage, O., and Langeveld, J. H. (1997). Maintenance electroconvulsive therapy for Parkinson's disease. Convuls. Ther., 13, 274–7.Google Scholar

Abas, M. A., Sahakian, B. J., and Levy, R. (1990). Neuropsychological deficits and CT scan changes in elderly depressives. Psychol. Med., 20, 507–20.Google Scholar

Abe, H., Honma, S., Namithira, M., et al. (1999). Circadian rhythm and light responsiveness of BMAL1 expression, a partner of mammalian clock gene, Clock, in the suprachiasmatic nucleus of rats. Neurosci. Lett., 258, 93–6.Google Scholar

Aben, I., Verhey, F., Lousberg, R., Lodder, J., and Honig, A. (2002). Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as screening instruments for depression in stroke patients. Psychosom., 43, 386–93.Google Scholar

Aben, I., Verhey, F., Strik, J., et al. (2003). A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J. Neurol. Neurosurg. Psychiatry, 74, 581–5.Google Scholar

Abercrombie, H. C., Schaefer, S. M., Larson, C. L., et al. (1998). Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuro. Report, 9, 3301–7.Google Scholar

Abkevich, V., Camp, N. J., Hensel, C. H., et al. (2003). Predisposition locus for major depression at chromosome 12q22–12q23. 2. Am. J. Hum. Genet., 73, 1271–81.Google Scholar

Ablon, J. S. and Jones, E. E. (2002). Validity of controlled clinical trials of psychotherapy: findings from the NIMH treatment of depression collaborative research program. Am. J. Psychiatry, 159, 775–83.Google Scholar

Abraham, K. (1927). Selected Papers of Karl Abraham. Translated by Bryan D. and Strachey, A. London: Hogarth Press, pp. 503–10.

Abrams, R. (1982). ECT and tricyclic antidepressants in the treatment of endogenous depression. Psychopharm. Bull., 18, 73–5.Google Scholar

Abrams, R.(ed.) (1989). ECT in the high-risk patient. Convuls. Ther., 6, 1–122.Google Scholar

Abrams, R.(1997). The mortality rate with ECT. Convuls. Ther., 3, 125–7.Google Scholar

Abrams, R.(2002a). Electroconvulsive Therapy, 4th edn. New York: Oxford University Press.

Abrams, R.(2002b). Stimulus titration and ECT dosing. J. ECT, 18, 3–9.Google Scholar

Abrams, R. and Swartz, C. M. (1985a). ECT and prolactin release: relation to treatment response in melancholia. Convuls. Ther., 1, 38–42.Google Scholar

Abrams, R. and Swartz, C. M.(1985b). ECT and prolactin release: effect of stimulus parameters. Convuls. Ther., 1, 115–119.Google Scholar

Abrams, R. and Taylor, M. A. (1976). Catatonia: a prospective study. Arch. Gen. Psychiatry, 33, 579–81.Google Scholar

Abrams, R. and Taylor, M. A.(1980). A comparison of unipolar and bipolar depressive illness. Am. J. Psychiatry, 137, 1084–7.Google Scholar

Abrams, R. and Taylor, M. A.(1983). The importance of mood-incongruent psychotic symptoms in melancholia. J. Affect. Disord., 5, 179–81.Google Scholar

Abrams, R., Volavka, J., Roubicek, J., Dornbush, R., and Fink, M. (1970). Lateralized EEG changes after unilateral and bilateral electroconvulsive therapy. Dis. Nerv. Syst., 31, (suppl.) 28–33.Google Scholar

Abrams, R., Fink, M., Dornbush, R., et al. (1972). Unilateral and bilateral ECT: effects on depression, memory and the electroencephalogram. Arch. Gen. Psychiatry, 27, 88–91.Google Scholar

Abrams, R., Volavka, J., and Fink, M. (1973). EEG seizure patterns during multiple unilateral and bilateral ECT. Compr. Psychiatry, 14, 25–8.Google Scholar

Abrams, R., Taylor, M. A., Faber, R., et al. (1983). Bilateral versus unilateral ECT: efficacy in melancholia. Am. J. Psychiatry, 140, 463–5.Google Scholar

Abrams, S. M., Field, T., Scafidi, F., and Prodromidis, M. (1995). Newborns of depressed mothers. Infant Mental Health J., 16, 233–9.Google Scholar

Abuzallouf, S., Dayes, I., and Lukka, H. (2004). Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J. Urol., 171, 2122–7.Google Scholar

Accornero, F. (1988). An eyewitness account of the discovery of electroshock. Convuls. Ther., 4, 40–9.Google Scholar

Ackerman, D. L., Greenland, S., Bystritsky, A., and Small, G. W. (1997). Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression. Psychopharmacol. Bull., 33, 707–14.Google Scholar

Adams, F. (ed.) (1939). The Genuine Works of Hippocrates. Baltimore: Williams & Wilkins

Addington, D. and Addington, J. (1990). Depression, dexamethasone nonsuppression and negative symptoms in schizophrenia. Can. J. Psychiatry, 35, 430–3.Google Scholar

Addington, D., Addington, J., Patten, S., et al. (2002). Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J. Clin. Psychopharmacol, 22, 20–5.Google Scholar

Adler, L., Wedekind, D., Pilz, J., Weniger, G., and Huether, G. (1997). Endocrine correlates of personality traits: a comparison between emotionally stable and emotionally labile healthy young men. Neuropsychobiology, 35, 205–10.Google Scholar

Adrian, E. D. and Matthews, B. H. C. (1934). The Berger rhythm: potential changes from the occipital lobes in man. Brain, 57, 355–85.Google Scholar

Adrien, J. (2002). Neurobiological bases for the relation between sleep and depression. Sleep Med. Rev., 6, 341–51.Google Scholar

Adson, D. E., Crow, S. J., Meller, W. H., and Magraw, R. M. (1998). Potential drug–drug interactions on a tertiary-care hospital consultation-liaison psychiatry service. Psychosom., 39, 360–5.Google Scholar

Affonso, D. D., Loven, S., Paul, S. M., and Sheptak, S. (1990). A standardized interview that differentiates pregnancy and postpartum symptoms from perinatal clinical depression. Birth, 17, 121–30.Google Scholar

Agargun, M. Y., Kara, H., and Solmaz, M. (1997). Sleep disturbances and suicidal behavior inpatients with major depression. J. Clin. Psychiatry, 58, 249–51.Google Scholar

Agence d'Évaluation des Technologies et des Modes d'Intervention en Santé (AETMIS) (2002). The use of electroconvulsive therapy in Quebec. AETMIS 02-05RE. Montreal: AETMIS.

Aharónovich, E., Liu, X., Nunes, E., and Hasin, D. S. (2002). Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am. J. Psychiatry, 159, 1600–2.Google Scholar

Ahearn, E. P., Jamison, K. R., Steffens, D. C., et al. (2001). MRI correlates of suicide attempt history in unipolar depression. Biol. Psychiatry, 50, 266–70.Google Scholar

Ahokas, A., Kaukoranta, J., and Aito, M. (1999). Effect of oestradiol on postpartum depression. Psychopharmacology, 146, 108–10.Google Scholar

Ahokas, A., Aito, M., and Turiainen, S. (2000). Association between oestradiol and puerperal psychosis. Acta Psychiatr. Scand., 101, 167–9.Google Scholar

Ahokas, A., Kaukoranta, J., Wahlbeck, K., and Aito, M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J. Clin. Psychiatry, 62, 332–6.Google Scholar

Ahrens, B., Grof, P., Möller, H. J., Muller-Oerlinghausen, B., and Wolf, T. (1995). Extended survival of patients on long-term lithium treatment. Can. J. Psychiatry, 40, 241–6.Google Scholar

Akdemir, A., Turkvapar, M. H., Orsel, S. D., et al. (2001). Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr. Psychiatry, 42, 161–5.Google Scholar

Akechi, T., Nakano, T., Okamura, H., et al. (2001). Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J. Clin. Oncol., 31, 188–94.Google Scholar

Akhondzadeh, S., Faraji, H., Sadeghi, M., et al. (2003). Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. J. Clin. Pharm. Ther., 28, 379–84.Google Scholar

Akiskal, H. S. (1981). Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr. Clin. North Am., 4, 25–46.Google Scholar

Akiskal, H. S.(1983a). Dysthymic disorder: psychopathology of proposed chronic depressive subtypes. Am. J. Psychiatry, 140, 11–20.Google Scholar

Akiskal, H. S.(1983b). Diagnosis and classification of affective disorders: new insights from clinical and laboratory approaches. Psych Dev., 2, 123–60.Google Scholar

Akiskal, H. S.(1990). Towards a definition of dysthymia: boundaries with personality and mood disorders. In Burton, S. W. and Akiskal, H. S. (eds) Dysthymic Disorder. London: Gaskell, pp. 1–12.

Akiskal, H. S.(ed.) (1999). Bipolarity: beyond classical mania. Psychiatr. Clin. North Am., 22, 517–703.Google Scholar

Akiskal, H. S. and Benazzi, F. (2003). Family history validation of the bipolar nature of depressive mixed states. J. Affect. Disord., 73, 113–22.Google Scholar

Akiskal, H. S. and Benazzi, F.(2004). Validating Kraepelin's two types of depressive mixed states: “depression with flight of ideas” and “excited depression.” World J. Biol. Psychiatry, 5, 107–13.Google Scholar

Akiskal, H. S. and Katona, C. (eds) (2001). Millennial issue: the new bipolar era. J. Affect. Disord., 67, 1–292.Google Scholar

Akiskal, H. S. and Pinto, O. (1999). The evolving bipolar spectrum: prototypes I, II, III, and IV. Psychiatr. Clin. North Am., 22, 517–34.Google Scholar

Akiskal, H. S., Rosenthal, T. H., Haykal, R. F., Lemmi, H., and Scott-Strauss, A. (1980). Characterological depressions: clinical and sleep EEG findings separating ‘subaffective dysthymias’ from ‘character spectrum’ disorders. Arch. Gen. Psychiatry, 37, 777–83.Google Scholar

Akiskal, H. S., Maser, J. D., Zeller, P. J., et al. (1995). Switching from ‘unipolar’ to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry, 52, 114–23.CrossRefGoogle Scholar

Akiskal, H. S., Benazzi, F., Perugi, G., and Rihmer, Z. (2005). Agitated “unipolar” depression reconceptualized as a depressive mixed state: implications for the antidepressant–suicide controversy. J. Affect. Disord., 85, 245–58.Google Scholar

Albala, A. A., Greden, J. F., Tarika, J., and Caroll, B. J. (1981). Changes in serial dexamethasone suppression tests among unipolar depressives receiving electroconvulsive treatment. Biol. Psychiatry, 16, 551–60.Google Scholar

Alderton, H. R. (1995). Tricyclic medication in children and the QT interval: case report and discussion. Can. J. Psychiatry, 40, 325–9.Google Scholar

Aldred, G. and Healy, D. (2004). Antidepressants and suicide. Br. Med. J., 329, (letter) 461.Google Scholar

Alexander, G. E. and Goldman, P. S. (1978). Functional development of the dorsolateral prefrontal cortex: an analysis utilizing reversible cryogenic depression. Brain Res., 143, 233–49.CrossRefGoogle Scholar

Alexander, R. C., Salomon, M., Ionescu-Poggia, M., and Cole, J. (1988). Convulsive therapy in the treatment of mania: McLean Hospital 1973–1986. Convuls. Ther., 4, 1152–5.Google Scholar

Alexopoulos, G. S., Young, R. C., and Abrams, R. C. (1989). ECT in the high-risk geriatric patient. Convuls. Ther., 5, 75–87.Google Scholar

Alexopoulos, G. S., Meyers, B. S., Young, R. C., et al. (1997). ‘Vascular depression’ hypothesis. Arch. Gen. Psychiatry, 54, 915–22.Google Scholar

Alexopoulos, G. S., Borson, S., Cuthbert, B. N., et al. (2002). Assessment of late life depression. Biol. Psychiatry, 52, 164–74.Google Scholar

Allain, H., Lieury, A., Brunet-Bourgin, F., et al. (1992). Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology, 106, S56–61.Google Scholar

Allain, H., Pollak, P., and Neukirch, H. C. (1993). Symptomatic effect of selegiline in de novo parkinsonian patients: the French Selegiline Multicenter Trial. Move. Disord., 8 (suppl. 1), S36–40.Google Scholar

Allard, P. and Norlen, M. (2001). Caudate nucleus dopamine D (2) receptors in depressed suicide victims. Neuropsychobiology, 44, 70–3.Google Scholar

Allen, J. M., Lam, R. W., Remick, R. A., and Sadovnick, A. D. (1993). Depressive symptoms and family history in seasonal and nonseasonal mood disorders. Am. J. Psychiatry, 130, 443–8.Google Scholar

Almeida-Montes, L. G.Valles-Sanchez, V., Moreno-Aguilar, J., et al. (2000). Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. J. Psychiatry Neurosci., 25, 371–7.Google Scholar

Alonso, S. J., Navarro, E., and Rodriguez, M. (1994). Permanent dopaminergic alterations in the n. accumbens after prenatal stress. Pharmacol. Biochem. Behav., 49, 353–8.Google Scholar

Alpert, J. E., Übelacker, L. A., McLean, N. E., et al. (1997). Social phobia, avordant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol. Med., 27, 627–33.Google Scholar

Altamura, C., Maes, M., Dai, J., and Meltzer, H. Y. (1995). Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur. Neuropsychopharmacol., 5 (suppl.), 71–5.Google Scholar

Altar, C. A., Whitehead, R. E., Chen, R., Wortwein, G., and Madsen, T. M. (2003). Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry, 54, 703–9.Google Scholar

Altshuler, L., Post, R. M., Leverich, G. S., et al. (1995). Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry, 152, 1130–8.Google Scholar

Altshuler, L., Kiriakos, L., Calcagno, J., et al. (2001c). The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J. Clin. Psychiatry, 62, 612–16.Google Scholar

Altshuler, L. L., Devinsky, O., Post, R. M., and Theodore, W. (1990). Depression, anxiety, and temporal lobe epilepsy: laterality of focus and symptoms. Arch. Neurol., 47, 284–8.Google Scholar

Altshuler, L. L., Cohen, L., Szuba, M. P., et al. (1996). Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry, 153, 592–606.Google Scholar

Altshuler, L. L., Bauer, M., Frye, M. A., et al. (2001a). Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatry, 158, 1617–22.Google Scholar

Altshuler, L. L., Cohen, L. S., Moline, M. L., et al. (2001b). Treatment of depression in women. Postgrad. Med., (special no.), 1–107.Google Scholar

Altshuler, L. L., Frye, M. A., and Gitlin, M. J. (2003). Acceleration and augmentation strategies for treating bipolar depression. Biol. Psychiatry, 53, 691–700Google Scholar

Alvarez, E., Perez-Sola, V., Perez-Blanco, J., et al. (1997). Predicting outcome of lithium added to antidepressants in resistant depression. J. Affect. Disord., 42, 179–86.Google Scholar

Ambrosini, P. J., Bennett, D. S., Cleland, C. M., and Haslam, N. (2002). Taxonicity of adolescent melancholia: a categorical or dimensional construct? J. Psychiatr. Res., 36, 247–56.Google Scholar

American College of Obstetricians and Gynecologists (2004). Hormone therapy. Obstet. Gynecol., 104, S49–55.

American Psychiatric Association (1952). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association Mental Health Service.

American Psychiatric Association(1968). DSM-II Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.

American Psychiatric Association(1978). Electroconvulsive Therapy. Task force report 22. Washington, DC: American Psychiatric Association.

American Psychiatric Association(1980). DSM-III. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.

American Psychiatric Association(1990). Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. Washington, DC: American Psychiatric Association.

American Psychiatric Association(1994). DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.

American Psychiatric Association(2001). The Practice of Electroconvulsive Therapy. Recommendations for Treatment, Training, and Privileging. 2nd edn. Washington, DC: American Psychiatric Association.

American Psychiatric Association(2002). Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry, 159 (4 suppl.), 1–50.

Amir, S. and Stewart, J. (1998). Conditioned fear suppresses light-induced resetting of the circadian clock. Neuroscience, 86, 345–51.Google Scholar

Amsterdam, J. D., Maislin, G., Winokur, A., et al. (1988). The DST/CRH stimulation test before and after clinical recovery from depression. J. Affect. Disord., 14, 213–22.Google Scholar

Anand, A. and Charney, D. S. (2000). Norepinephrine dysfunction in depression. J. Clin. Psychiatry, 61 (suppl. 1), 16–24.Google Scholar

Anderson, I. M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J. Affect. Disord., 58, 19–36.Google Scholar

Andersen, G., Vestergaard, K., and Lauritzen, L. (1994). Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 25, 1099–104.Google Scholar

Andersen, K., Balldin, J., Gottfries, C. G., et al. (1987). A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with “on–off ” phenomenon. Acta. Neurol. Scand., 76, 191–9.Google Scholar

Anderson, I. M.(2001). Meta-analytical studies on new antidepressants. Br. Med. Bull., 57, 161–78.CrossRefGoogle Scholar

Anderson, I. M. and Tomenson, B. M. (1994). The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J. Psychopharmacol., 8, 238–49.Google Scholar

Andreasen, N., Rice, J., Endicott, J., et al. (1987). Familial rates of affective disorder. Arch. Gen. Psychiatry, 44, 461–9.Google Scholar

Andreasen, N. C. and Grove, W. M. (1982). The classification of depression: traditional versus mathematic approaches. Am. J. Psychiatry, 139, 45–52.Google Scholar

Andreasen, N. C., Grove, W. M., and Maurer, R. (1980). Cluster analysis and the classification of depression. Br. J. Psychiatry, 137, 256–65.Google Scholar

Andrew, B., Hawton, K., Fagg, J., and Westbrook, D. (1993). Do psychosocial factors influence outcome in severely depressed female psychiatric outpatients? Br. J. Psychiatry, 163, 747–54.Google Scholar

Angell, M. (2004). The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.

Angst, J. (1966). Zur Atiologie and Nosologie endogener depressiver Psychosen. Berlin: Springer.

Angst, J.(1978). The course of affective disorders: II: typology of bipolar manic-depressive illness. Arch Psychiatr. Nevenkro, 226, 65–73.Google Scholar

Angst, J.(1985). Switch from depression to mania – a record study over decades between 1920 and 1982. Psychopathology, 18, 140–54.Google Scholar

Angst, J(1987). Switch from depression or mania, or from mania to depression: Role of psychotropic drugs. Psychopharm. Bull., 23, 66–7.Google Scholar

Angst, J.(1997). Minor and recurrent brief depression. In Akiskal, H. S., and Cassano, G. B. (eds) Dysthymia and the Spectrum of Chronic Depressions. New York: Guilford Press, pp. 183–90.

Angst, J. and Marneros, A. (2001). Bipolarity from ancient to modern times: conception, birth and rebirth. J. Affect. Disord., 67, 3–19.Google Scholar

Angst, J. and Perris, C. (1972). The nosology of endogenous depression: comparison of the results of two studies. Int. J. Mental Health, 1, 145–58.Google Scholar

Angst, J. and Preisig, M. (1995). Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz. Arch. Neurol. Psychiatr., 146, 17–23.Google Scholar

Angst, J., Dittrich, A., and Grof, P. (1969). Course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int. Pharmacopsychiatry, 2, 1–11.Google Scholar

Angst, J., Angst, K., Baruffol, I., and Meinherz-Surbeck, R. (1992). ECT-induced and drug-induced hypomania. Convuls. Ther., 8, 179–85.Google Scholar

Angst, J., Gamma, A., Sellaro, R., Zhang, H., and Merikangas, K. (2002). Toward validation of atypical depression in the community: results of the Zurich cohort study. J. Affect. Disord., 72, 125–38.Google Scholar

Angst, J., Sellaro, R., Stassen, H. H., and Gamma, A. (2005). Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J. Affect. Disord., 84, 149–57.Google Scholar

Anisman, H., Ravindran, A. V., Griffiths, J., and Merali, Z. (1999). Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol. Psychiatry, 4, 182–8.Google Scholar

Anton, R. F., Moak, D. H., Waid, L. R., et al. (1999). Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics. Am. J. Psychiatry, 156, 1758–64.Google Scholar

Anton, R. F., Moak, D. H., Latham, P. K., et al. (2001). Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J. Clin. Psychopharmacol., 21, 72–7.Google Scholar

Antonijevic, I. A., Murck, H., Frieboes, R. M., and Steiger, A. (2000a). Sexually dimorphic effects of GHRH on sleep-endocrine activity inpatients with depression and normal controls – part II: hormone secretion. Sleep Res. Online, 3, 15–21.Google Scholar

Antonijevic, I. A., Stalla, G. K., and Steiger, A. (2000b). Modulation of the sleep electroencephalogram by oestrogen replacement in postmenopausal women. Am. J. Obstet. Gynecol., 182, 277–82.Google Scholar

Antonijevic, I. A., Murck, H., Frieboes, R.-M., Uhr, M., and Steiger, A. (2003). On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology, 28, 401–18.Google Scholar

APA Task Force on Laboratory Tests in Psychiatry (1987). The dexamethasone suppression test: an overview of its current status in psychiatry. Am. J. Psychiatry, 144, 1253–62.

Apgar, V. (1953). A proposal for a new method of evaluation of the newborn infant. Curr. Res. Anesth. Analg., 32, 260–7.Google Scholar

Apgar, V.(1962). Further observations on the newborn scoring system. Am. J. Dis. Child., 104, 419–28.Google Scholar

Appelhof, B. C., Brouwer, J. P., Dyck, R., et al. (2004). Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. J. Clin. Endocrinol. Metab., 89, 6271–6.Google Scholar

Arana, G. W., Baldessarini, R. J., and Ornsteen, M. (1985). The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry, 42, 1193–204.Google Scholar

Arango, V., Underwood, M. D., and Mann, J. J. (2002). Serotonin brain circuits involved in major depression and suicide. Prog. Brain Res., 136, 443–53.Google Scholar

Arborelius, L., Owens, M. J., Plotsky, P. M., and Nemeroff, C. B. (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol, 160, 1–12.Google Scholar

Arciniegas, D. B. and Anderson, C. A. (2002). Suicide in neurologic illness. Curr. Treat. Options Neurol., 4, 457–68.Google Scholar

Arean, P. A. and Cook, B. L. (2002). Psychotherapy and combined psychotherapy/pharmacotherapy for late life depression. Biol. Psychiatry, 52, 293–303.Google Scholar

Arias, B., Catalan, R., Gasto, C., et al. (2001). Genetic variability in the promoter region of the serotonin transporter gene is associated with clinical remission of major depression after long term treatment with citalopram. World J. Biol. Psychiatry, 2, 9.Google Scholar

Armitage, R. (2000). The effects of antidepressants on sleep in patients with depression. Can. J. Psychiatry, 45, 803–9.Google Scholar

Armitage, R., Emslie, G., and Rintelmann, J. (1997a). The effect of fluoxetine on sleep EEG in childhood depression: a preliminary report. Neuropsychopharm., 17, 241–5.Google Scholar

Armitage, R., Yonkers, K., Cole, D., and Rush, A. J. (1997b). A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J. Clin. Psychopharmacol., 17, 161–8.Google Scholar

Armitage, R., Hoffmann, R. F., and Rush, A. J. (1999). Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms. Psychol. Med., 29, 1435–48.Google Scholar

Armitage, R., Emslie, G. J., Hoffmann, R. F., et al. (2000a). Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents. Biol. Psychiatry, 47, 338–50.Google Scholar

Armitage, R., Hoffmann, R. F., Fitch, T., Trivedi, M., and Rush, A. J. (2000b). Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep, 23, 607–17.Google Scholar

Armitage, R., Hoffmann, R., Trivedi, M., and Rush, A. J. (2000c). Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res., 95, 201–13.Google Scholar

Armitage, R., Hoffmann, R. F., Fitch, T., Trivedi, M., and Rush, A. J. (2000d). Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep, 23, 607–17.Google Scholar

Armitage, R., Emslie, G. J., Hoffmann, R. F., Rintelmann, J., and Rush, A. J. (2001). Delta sleep EEG in depressed adolescent females and healthy controls. J. Affect. Disord., 63, 139–48.Google Scholar

Armitage, R., Hoffmann, R. F., Emslie, G. J., et al. (2002). Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression. Int. J. Neuropsychopharmacol., 5, 217–28.Google Scholar

Armitage, R., Husain, M., Hoffmann, R., and Rush, A. J. (2003). The effects of vagus nerve stimulation on sleep EEG in depression. J. Psychosom. Res., 54, 475–82.Google Scholar

Arnold, O. H. and Stepan, H. (1952). Untersuchungen zur Frage der akuten tödliche Katatonie. Wr. Z. Nerven., 4, 235–87.Google Scholar

Arnsten, A. F., Mathew, R., Ubriani, R., Taylor, J. R., and Li, B. M. (1999). Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol. Psychiatry, 45, 26–31.Google Scholar

Aronson, R., Offman, H. J., Joffe, R. T., and Naylor, C. D. (1996). Triiodothyronine augmentation in the treatment of refractory depression. Arch. Gen. Psychiatry, 53, 842–8.Google Scholar

Aronson, T. (1987). Continuation therapy after ECT for delusional depression: a naturalistic study of prophylactic treatments and relapse. Convuls. Ther., 3, 251–9.Google Scholar

Ascher, E. (1951/52). A criticism of the concept of neurotic depression. Am. J. Psychiatry, 108, 901–8.Google Scholar

Ashton, C. H., Marshall, E. F., Hassanyeh, F., Marsh, V. R., and Wright-Honari, S. (1994). Biological correlates of deliberate self-harm behaviour: a study of electroencephalographic, biochemical and psychological variables in parasuicide. Acta Psychiatr. Scand., 90, 316–23.Google Scholar

Attwood, A., Frith, U., and Hermelin, B. (1988). The understanding of interpersonal gestures by autistic and Down syndrome children. J. Autism Dev. Disord., 18, 241–57.Google Scholar

Aubert, R. E., Fulop, G., Xia, F., et al. (2003). Evaluation of a depression health management program to improve outcomes in first or recurrent episode depression. Am. J. Manag. Care, 9, 374–80.Google Scholar

Auer, D. P., Putz, B., Kraft, E., et al. (2000). Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry, 47, 305–13.Google Scholar

Austin, M. C., Whitehead, R. E., Edgar, C. L., Janosky, J. E., and Lewis, D. A. (2002). Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neurosci., 114, 807–15.Google Scholar

Austin, M. P., Ross, M., Murray, C., et al. (1992). Cognitive function in major depression. J. Affect. Disord., 25, 21–9.Google Scholar

Austin, M. P., Mitchell, P., Wilhelm, K., et al. (1999). Cognitive function in depression: a distinct pattern of frontal impairment in melancholia? Psychol. Med., 29, 73–85.Google Scholar

Austin, M. P., Mitchell, P., and Goodwin, G. M. (2001). Cognitive deficits in depression. Br. J. Psychiatry, 178, 200–6.Google Scholar

Avery, D. and Lubrano, A. (1979). Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am. J. Psychiatry, 136, 559–62.Google Scholar

Avery, D. and Winokur, G. (1977). The efficacy of electroconvulsive therapy and antidepressants in depression. Biol. Psychiatry, 12, 507–23.Google Scholar

Avery, D. H., Dahl, K., Savage, M. V., et al. (1997). Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression. Biol. Psychiatry, 41, 1109–23.Google Scholar

Avery, D. H., Eder, D. N., Bolte, M. A., et al. (2001). Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol. Psychiatry, 50, 205–16.Google Scholar

Avissar, S., Nechamkin, Y., Roitman, G., and Schreiber, G., (1997). Reducecd. G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. Am. J. Psychiatry, 154, 211–17.Google Scholar

Axelson, D. A., Doraiswamy, P. M., McDonald, W. M., et al. (1993). Hypercortisolemia and hippocampal changes in depression. Psychiatry Res., 47, 163–73.Google Scholar

Ayuso-Gutierrez, J., Cabranes, J., Garcia-Camba, E., and Almoguera, I. (1987). Pituitary-adrenal disinhibition and suicide attempts in depressed patients. Biol. Psychiatry, 22, 1409–12.Google Scholar

Ayuso-Mateos, J. L., Vazquez-Barquero, J. L., Dowrick, C., et al. (2001). Depressive disorders in Europe: prevalence figures from the ODIN study. Br. J. Psychiatry, 179, 308–16.Google Scholar

Azmitia, E. C. and Segal, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641–67.Google Scholar

Baca-Garcia, E., Blanco, C., Saiz-Ruiz, J., et al. (2001). Assessment of reliability in the clinical evaluation of depressive symptoms among multiple investigators in a multicenter clinical trial. Psychiatry Res., 102, 163–73.Google Scholar

Baca-Garcia, E., Diaz-Sastre, C., Ceverino, A., et al. (2003). Association between the menses and suicide attempts: a replication study. Psychosom. Med., 65, 237–44.Google Scholar

Bachmann, S., Bottmer, C., Jacob, S., et al. (2002). Expressed emotion in relatives of first-episode and chronic patients with schizophrenia and major depressive disorder – a comparison. Psychiatry Res., 112, 239–50.Google Scholar

Baethge, C., Salvatore, P., and Baldessarini, R. J. (2003a). “On cyclic insanity” by Ludwig, Karl, Kahlbaum, MD: a translation and commentary. Harv. Rev. Psychiatry, 11, 78–90.Google Scholar

Baethge, C., Salvatore, P., and Baldessarini, R. J.(2003b). Cyclothymia, a circular mood disorder. Hist. Psychiatry, 14, 377–99.Google Scholar

Baethge, C., Gruschka, P., Smolka, M. N., et al. (2003c). Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder. J. Psychiatry Neurosci., 28, 355–61.Google Scholar

Bagby, R. M., Ryder, A. G., and Cristi, C. (2002). Psychosocial and clinical predictors of response to pharmacotherapy for depression. J. Psychiatry Neurosci., 27, 250–7.Google Scholar

Baghai, T. C., Schule, C., Zwanzger, P., et al. (2003a). Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression. Neurosci. Lett., 339, 223–6.Google Scholar

Baghai, T. C., Schule, C., Zwanzger, P.(2003b). No influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression. World J. Biol. Psychiatry, 4, 111–4.Google Scholar

Bailine, S. H., Rifkin, A., Kayne, E., et al. (2000). Comparison of bifrontal and bitemporal ECT for major depression. Am. J. Psychiatry, 157, 121–3.Google Scholar

Bailine, S. H., Petrides, G., Doft, M., and Lui, G. (2003). Indications for the use of propofol in electroconvulsive therapy. J. ECT, 19, 129–32.Google Scholar

Baillerger, J. (1854). De la folie à double forme. Ann. Med. Psychol., 6, 367–91.Google Scholar

Baker, A. A., Morison, M., Game, J. A., and Thorpe, J. G. (1961). Admitting schizophrenic mothers with their babies. Lancet, 2, 237–9.Google Scholar

Baker, C. B., Johnsrud, M. T., Crismon, M. L., Rosenheck, R. A., and Woods, S. W. (2003). Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br. J. Psychiatry, 183, 498–506.Google Scholar

Baker, R. A. and Herkenham, M. (1995). Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J. Comp. Neurol., 358, 518–30.Google Scholar

Bakish, D. (2001). New standard of depression treatment: remission and full recovery. J. Clin. Psychiatry, 62 (suppl. 26), 5–9.Google Scholar

Baldessano, C. F., Datto, S. M., Littman, L., and Lipari, M. A. (2003). What drugs are best for bipolar depression? Ann. Clin. Psychiatry, 15, 225–32.Google Scholar

Baldessarini, R. J. (2001). Drugs and the treatment of psychiatric disorders: antidepressant and antianxiety agents. In Hardman, J. G., Limbird, L. E., and Gilman, A. G. (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill, pp. 447–83.

Baldessarini, R. J. and Tondo, L. (2003). Suicide risk and treatments for patients with bipolar disorder. J.A.M.A., 290, 1517–19.Google Scholar

Baldessarini, R. J., Tondo, L., Floris, G., and Hennen, J. (2000). Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J. Affect. Disord., 61, 13–22.Google Scholar

Baldessarini, R. J., Tondo, L., and Hennen, J. (2001). Treating the suicidal patient with bipolar disorder: reducing suicide risk with lithium. Ann. N. Y. Acad. Sci., 932, 24–38.Google Scholar

Baldwin, D. S., Hawley, C. J., Abed, R. T., et al. (1996). A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression. J. Clin. Psychiatry, 57 (suppl. 2), 46–52.Google Scholar

Baldwin, R. C. (2005). Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int. J. Geriatr. Psychiatry, 20, 1–11.Google Scholar

Baldwin, R. C. and O'Brien, J. (2002). Vascular basis of late-onset depressive disorder. Br. J. Psychiatry, 180, 157–60.Google Scholar

Baldwin, R. C. and Tomenson, B. (1995). Depression in later life: a comparison of symptoms and risk factors in early- and late-onset cases. Br. J. Psychiatry, 167, 649–52.Google Scholar

Bale, T. L., Contarino, A., Smith, G. W., et al. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet., 24, 410–14.Google Scholar

Ballard, C., Banniester, C., Solis, M., Oyebode, F., and Wilcock, G. (1996). The prevalence, associations and symptoms of depression amongst dementia sufferers. J. Affect. Disord., 36, 135–44.Google Scholar

Ballon, N., Siobud-Dorocant, E., Even, C., Slama, F., and Dardennes, R. (2001) Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study. Encephale, 27, 373–6.Google Scholar

Ban, T. A., Healy, D., and Shorter, E. (1998). The Triumph of Psychopharmacology and the Story of CINP. Budapest:Animula.

Ban, T. A., Healy, D., and Shorter, E.(2000). The Triumph of Psychopharmacology and the Story of CINP. Budapest: Animula.

Ban, T. A., Healy, D., and Shorter, E.(2002). The Rise of Psychopharmacology and the Story of CINP. Budapest:Animula.

Ban, T. A., Healy, D., and Shorter, E.(2004).Reflections on Twentieth-Century Psychopharmacology. Budapest:Animula.

Banki, C., Arato, M., Papp, Z., and Kurcz, M. (1984). Biochemical markers in suicidal patients. J. Affect. Disord., 6, 341–50.Google Scholar

Baran, A. S. and Richert, A. C. (2003). Obstructive sleep apnea and depression. CNS Spectr., 8, 120–34.Google Scholar

Barbui, C. and Hotopf, M. (2001). Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br. J. Psychiatry, 178, 129–44.Google Scholar

Barclay, M. L., Brownlie, B. E. W., Turner, J. G., and Wells, J. E. (1994). Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin. Endocrinol., 40, 759–64.Google Scholar

Barden, N., Reul, J. M. H. M., and Holsboer, F. (1995). Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci., 18, 6–11.Google Scholar

Bardwell, W. A., Moore, P., Ancoli-Israel, S., and Dimsdale, J. E. (2003). Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? Am. J. Psychiatry, 160, 350–5.Google Scholar

Barraclough, B., Bunch, J., Nelson, B., and Sainsbury, P. (1974). One hundred cases of suicide: clinical aspects. Br. J. Psychiatry, 125, 355–73.Google Scholar

Bauer, M. and Dopfmer, S. (1999). Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol., 19, 427–34.CrossRefGoogle Scholar

Bauer, M., Bschor, T., Kunz, D., et al. (2000). Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am. J. Psychiatry, 157, 1429–35.Google Scholar

Baumhackl, U., Biziere, K., Fischbach, R., et al. (1989). Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. Br. J. Psychiatry, 155 (suppl.), 78–83.Google Scholar

Baxter, H., Singh, S. P., Standen, P., and Duggan, C. (2001). The attitudes of ‘tomorrow's doctors’ towards mental illness and psychiatry: changes during the final undergraduate year. Med. Educ., 35, 381–3.Google Scholar

Bazin, N., Perruchet, P., Bonis, R., and Feline, A. (1994). The dissociation of explicit and implicit memory in depressed patients. Psychol. Med., 24, 239–45.Google Scholar

Beardslee, W. R., Keller, M. B., Seifer, R., et al. (1996). Prediction of adolescent affective disorder: effects of prior parental affective disorders and child psychopathology. J. Am. Acad. Child Adolesc. Psychiatry, 35, 279–88.CrossRefGoogle Scholar

Beats, B. C., Sahakian, B. J., and Levy, R. (1996). Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol. Med., 26, 591–603.Google Scholar

Beautrais, A. L. (2003). Suicide and serious suicide attempts in youth: a multiple-group comparison study. Am. J. Psychiatry, 160, 1093–9.Google Scholar

Bech, P. and Rafaelsen, O. J. (1980). The use of rating scales exemplified by a comparison of the Hamilton and the Bech Rafaelsen Melancholia Scale. Acta Psychiatr. Scand., 62 (suppl. 185), 128–32.Google Scholar

Bech, P., Cialdella, P., Haugh, M. C., et al. (2000). Meta-analysis of randomized controlled trial of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br. J. Psychiatry, 176, 421–8.Google Scholar

Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., and Erbaugh, J. (1961). An inventory for measuring depression. Arch. Gen. Psychiatry, 4, 53–63.Google Scholar

Beck, A. T., Brady, J. P., and Quen, J. M. (1977). The history of depression. Psychiatr. Ann., 7, 1–50.Google Scholar

Beck, C. T. (1996). A meta-analysis of predictors of postpartum depression. Nurs. Res., 45, 297–303.Google Scholar

Beekman, A. T. F., Copeland, J. R. M., and Prince, M. J. (1999). Review of community prevalence of depression in later life. Br. J. Psychiatry, 174, 307–11.Google Scholar

Beer, A. M. and Ostermann, T. (2001). St. John's wort: interaction with cyclosporine increases risk of rejection for the kidney transplant and raises daily cost of medication. Med. Klin., 96, 480–3.Google Scholar

Beier, E. V., Arushanian, E. B., Titenok, A. L., and Alferor, V. V. (2003). The dorsal hippocampus injury influences chronobiological effects of depressants and antidepressants in rats. Eksp. Klin. Farmakol., 66, 9–12.Google Scholar

Belanoff, J., Flores, B., Kalezhan, M., Sund, B., and Schatzberg, A. (2001a). Rapid reversal of psychotic major depression using mifepristone. J. Clin. Psychopharmacol., 21, 516–54.Google Scholar

Belanoff, J. K., Kalehzan, M., Sund, B., Fleming Ficek, S. K., and Schatzberg, A. F. (2001b). Cortisol activity and cognitive changes in psychotic major depression. Am. J. Psychiatry, 158, 1612–16.Google Scholar

Belanoff, J. K., Rothschild, A. J., Cassidy, F., et al. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol. Psychiatry, 52, 386–92.Google Scholar

Bell, H., Tallaksen, C. M., Try, K., and Haug, E. (1994). Carbohydrate-deficient transferring and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin. Exp. Res., 18, 1103–8.Google Scholar

Bellini, L., Gatti, F., Gasperini, M., and Smeraldi, E. (1992). A comparison between delusional and nondelusional depressives. J. Affect. Disord., 25, 129–38.Google Scholar

Bellush, L. L. and Reid, S. G. (1994). Metabolic and neurochemical profiles in insulin-treated diabetic rats. Am. J. Physiol., 266, R87–94.Google Scholar

Benazzi, F. (1999). Atypical depression in private practice depressed outpatients: a 203-case study. Compr. Psychiatry, 40, 80–3.Google Scholar

Benazzi, F.(1999c). Psychotic late-life depression: a 376-case study. Int. Psychogeriatr., 11, 325–32.Google Scholar

Benazzi, F.(2000). Late-life atypical major depressive episode. A 358-case study in outpatients. Am. J. Geriatr. Psychiatry, 8, 117–22.Google Scholar

Benazzi, F.(2001). Prevalence and clinical correlates of residual depressive symptoms in bipolar II disorder. Psychother. Psychosom., 70, 232–8.Google Scholar

Benazzi, F.(2002). Psychomotor changes in melancholic and atypical depression: unipolar and bipolar-II subtypes. Psychiatry Res., 112, 211–20.Google Scholar

Benazzi, F.(2003a). Is there a link between atypical and early-onset “unipolar” depression and bipolar II disorder? Compr. Psychiatry, 44, 102–9.Google Scholar

Benazzi, F.(2003b). Bipolar II disorder and major depressive disorder: continuity or discontinuity? World J. Biol. Psychiatry, 4, 166–71.Google Scholar

Benazzi, F.(2004a). Melancholic outpatient depression in bipolar-II vs. unipolar. Prog. Neuro-psychopharm. Biol. Psychiatry, 28, 481–5.Google Scholar

Benazzi, F.(2004b). Depressive mixed state: a feature of the natural course of bipolar II (and major depressive) disorder? Psychopathology, 7, 207–12.Google Scholar

Benazzi, F.(2004c). Is depressive mixed state a transition between depression and hypomania? Eur. Arch. Psychiatry Clin. Neurosci., 254, 69–75.Google Scholar

Benazzi, F.(2004d). Agitated depression: a valid depression subtype? Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, 1279–85.Google Scholar

Benazzi, F. and Akiskal, H. S. (2001). Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J. Affect. Disord., 67, 115–22.Google Scholar

Benazzi, F., and Akiskal, H. S.(2003). Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J. Affect. Disord., 73, 33–8.Google Scholar

Benazzi, F., and Rihmer, Z. (2000). Sensitivity and specificity of DSM-IV atypical features for bipolar II disorder diagnosis. Psychiatry Res., 93, 257–62.Google Scholar

Benazzi, F., Koukopolous, A., and Akiskal, H. S. (2004). Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur. Psychiatry, 19, 85–90.Google Scholar

Benbow, S. M., Benbow, J., and Tomenson, B. (2003). Electroconvulsive therapy clinics in the United Kingdom should routinely monitor electroencephalographic seizures. J. ECT, 19, 217–20.Google Scholar

Benca, R. M., Obermeyer, W. H., Thisted, R. A., and Gillin, J. C. (1992). Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiatry, 49, 651–68.Google Scholar

Bench, C. J., Friston, K. J., Brown, R. G., et al. (1993). Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol. Med., 23, 579–90.Google Scholar

Benedetti, F., Colombo, C., Pontiggia, A., et al. (2003a). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J. Clin. Psychiatry, 64, 648–53.Google Scholar

Benedetti, F., Colombo, C., Serretti, A., et al. (2003b). Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol. Psychiatry, 54, 687–92.Google Scholar

Bennett, A. E. (1938). Convulsive (pentamethyline-tetrazol) shock therapy in depressive psychosis: preliminary report of results obtained in ten cases. Am. J. Med. Sci., 196, 420–8.CrossRefGoogle Scholar

Bennett, A. E.(1939). Metrazol convulsive shock therapy in affective psychoses; follow-up report of results in 61 depressive and 9 manic cases. Am. J. Med. Sci., 198, 695–701.Google Scholar

Bennett, A. E.(1972). Fifty Years in Neurology and Psychiatry. New York:Intercontinental Medical Book.

Benoit, D., Zeanah, C. H., Boucher, C., and Minde, K. (1992). Sleep disorders in early childhood: association with insecure maternal attachment. J. Am. Acad. Child Adolesc. Psychiatry, 31, 86–93.Google Scholar

Ben-Shachar, D., Gawawi, H., Riboyad-Levin, J., and Klein, E. (1999). Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res., 81, 678–83.Google Scholar

Bent-Hansen, J., Lauritzen, L., Clemmesen, L., Lunde, M., and Korner, A. (1995). A definite and a semidefinite questionnaire version of the Hamilton/melancholia (HDS/MES) scale. J. Affect. Disord., 33, 143–50.Google Scholar

Bent-Hansen, J., Lunde, M., Klysner, R., et al. (2003). The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry, 36, 313–16.Google Scholar

Berenbaum, S. A., Abrams, R., Rosenberg, S., and Taylor, M. A. (1987). The nature of emotional blunting: a factor-analytic study. Psychiatry Res., 20, 57–67.Google Scholar

Berger, M., Pirke, K.-M., Doerr, P., Krieg, J.-C., and Zerssen, D. (1984). The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br. J. Psychiatry, 145, 372–82.Google Scholar

Berger, M., Calker, D., and Riemann, D. (2003). Sleep and manipulations of the sleep-wake rhythm in depression. Acta Psychiatr. Scand. Suppl., 418, 83–91.Google Scholar

Berman, R. L., Darnell, A. M., Miller, H. L., Anand, A., and Charney, D. S. (1997). Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am. J. Psychiatry, 154, 37–43.Google Scholar

Berns, G. S., Martin, M., and Proper, S. M. (2002). Limbic hyperreactivity in bipolar II disorder. Am. J. Psychiatry, 159, 304–6.Google Scholar

Berrios, G. and Porter, R. (1995). A History of Clinical Psychiatry. London: Athlone Press.

Berrios, G. E., Luque, R.(1995b). Cotard's syndrome: analysis of 100 cases. Acta Psychiatr. Scand., 91, 185–8.Google Scholar

Berrios, G. E. and Luque, R. (1995a). Cotard's delusion or syndrome? A conceptual history. Compr. Psychiatry, 36, 218–23.Google Scholar

Bertelsen, A., Harvald, B., and Hauge, M. (1977). A Danish twin study of manic-depressive disorders. Br. J. Psychiatry, 130, 330–51.Google Scholar

Bertolino, A., Frye, M., Callicott, J. H., et al. (2003). Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry, 53, 906–13.Google Scholar

Bethea, C. L., Pecins-Thompson, M., Schutzer, W. E., Gundlah, C., and Lu, Z. N. (1999). Ovarian steroids and serotonin neural function. Mol. Neurobiol., 18, 87–123.Google Scholar

Beyer, J. L., Weiner, R. D., and Glenn, M. D. (1998). Electroconvulsive Therapy. A Programmed Text. Washington, DC:American Psychiatric Press.

Bhandari, M., Busse, J. W., Jackowski, D., et al. (2004). Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. C.M.A.J., 170, 477–80.Google Scholar

Bianchi, J. A. and Chiarello, C. J. (1944). Shock therapy in the involutional and manic-depressive psychoses. Psych. Q., 18, 118–26.Google Scholar

Bielski, R. J., Mayor, J., and Rice, J. (1992). Phototherapy with broad spectrum white fluorescent light: A comparative study. Psychiatry Res., 43, 167–75.Google Scholar

Bilikiewicz, A. (1999). Medical student curriculum in psychiatry in Poland. Psychiatr. Pol., 33, 169–77.Google Scholar

Birchwood, M., Iqbal, Z., Chadwick, P., and Trower, P. (2000). Cognitive approach to depression and suicidal thinking in psychosis. I. Ontogeny of post-psychotic depression. Br. J. Psychiatry, 117, 516–21.Google Scholar

Birkenhäger, T. K., Pluijms, E. M., and Lucius, S. A. P. (2003). ECT response in delusional versus non-delusional depressed inpatients. J. Affect. Disord., 74, 191–5.Google Scholar

Birmaher, B., Arbelaez, C., and Brent, D. (2002). Course and outcome of child and adolescent major depressive disorder. Child Adolesc. Psychiatr. Clin. North Am., 11, 619–37.Google Scholar

Birmaher, B., Ryan, N. D., Williamson, D. E., et al. (1996a). Childhood and adolescent depression: a review of the past 10 years. Part I. J. Am. Acad. Child Adolesc. Psychiatry, 35, 1427–39.Google Scholar

Birmaher, B., Williamson, D. E., Dahl, R. E., et al. (2004). Clinical presentation and course of depression in youth: does onset in childhood differ from onset in adolescence? J. Am. Acad. Child Adolesc. Psychiatry, 43, 63–70.Google Scholar

Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A., and Kaufman, J. (1996b). Childhood and adolescent depression. A review of the past 10 years. Part II. J. Am. Acad. Child Adolesc. Psychiatry, 35, 1575–83.Google Scholar

Biro, M., and Till, E. (1989). Factor analytic study of depressive disorders. J. Clin. Psychol., 45, 369–73.3.0.CO;2-D>CrossRefGoogle Scholar

Bissessur, S., Tissingh, G., Wolters, E. C., and Scheltens, P. (1997). rCBF SPECT in Parkinson's disease with mental dysfunction. J. Neural Transm., 50 (suppl.), 25–30.Google Scholar

Biver, F., Goldman, S., Delvenne, V., et al. (1994). Frontal and parietal metabolic disturbances in unipolar depression. Biol. Psychiatry, 36, 381–8.Google Scholar

Black, D. W., Winokur, G., and Nasrallah, A. (1987a). The treatment of depression: electroconvulsive therapy vs antidepressants: a naturalistic evaluation of 1495 patients. Compr. Psychiatry, 26, 169–82.Google Scholar

Black, D. W., Winokur, G., and Nasrallah, A.(1987b). Suicide on subtypes of major affective disorder. A comparison with general population suicide mortality. Arch. Gen. Psychiatry, 44, 878–80.Google Scholar

Black, D. W., Winokur, G., and Nasrallah, A.(1988). Effect of psychosis on suicide risk in 1593 patients with unipolar and bipolar affective disorders. Am. J. Psychiatry, 145, 849–52.Google Scholar

Black, D. W., Monohan, P. O., and Winokur, G. (2002). The relationship between DST results and suicidal behavior. Ann. Clin. Psychiatry, 14, 83–8.Google Scholar

Black, D. W. G., Wilcox, J. A., and Stewart, M. (1985). The use of ECT in children: case report. J. Clin. Psychiatry, 46, 98–9.Google Scholar

Blair-West, G. W., Cantor, C. H., Mellsop, G. W., and Eyeson-Annan, M. L. (1999). Lifetime suicide risk in major depression: sex and age determinants. J. Affect. Disord., 55, 171–8.Google Scholar

Blanco, C., Laje, G., Olfson, M., Marcus, S. C., and Pincus, H. A. (2002). Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry, 15a, 1005–10.Google Scholar

Blashfield, R. K. and Morey, L. C. (1979). The classification of depression through cluster analysis. Compr. Psychiatry, 20, 516–27.Google Scholar

Blazer, D., Swartz, M., Woodbury, M., et al. (1988). Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. Arch. Gen. Psychiatry, 45, 1078–84.Google Scholar

Blazer, D. G., Kessler, R. L., McGonagle, K. A., and Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am. J. Psychiatry, 151, 979–86.Google Scholar

Blier, P. and Ward, N. M. (2003). Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry, 53, 193–203.Google Scholar

Bligh-Glover, W., Kolli, T. N., Shapiro-Kulnane, L., et al. (2000). The serotonin transporter in the midbrain of suicide victims with major depression. Biol. Psychiatry, 47, 1015–24.Google Scholar

Blinder, M. G. (1969). Classification and treatment of depression. Int. Psychiatry Clin., 6, 3–26.Google Scholar

Bloch, M., Schmidt, P. J., Danaceau, M., et al. (2000). Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry, 157, 924–30.Google Scholar

Bloch, M., Daly, R. C., and Rubinow, D. R. (2003). Endocrine factors in the etiology of postpartum depression. Compr. Psychiatry, 44, 234–46.Google Scholar

Bloch, Y., Ratzoni, G., Sobol, D., et al. (2005). Gender differences in electroconvulsive therapy: a retrospective chart review. J. Affect. Disord., 84, 99–102.Google Scholar

Block, M., Schwartzman, Y., Bonne, O., and Lerer, B. (1977). Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study. J. Clin. Psychopharmacol., 17, 44–8.Google Scholar

Block, S. D. (1994). The primary care imperative: challenges and opportunities for medical student education in psychiatry. Harv. Rev. Psychiatry, 2, 52–4.Google Scholar

Blumberg, A. G., Cohen, L., and Miller, J. S. A. (1956). The relation of mecholyl induced hypotension to the classification of psychiatric patients and its prognostic significance with electroshock therapy. J. Hillside Hosp., 5, 216–31.Google Scholar

Blumberg, H. P., Stern, E., Martinez, D., et al. (2000). Increased anterior cingulate and caudate activity in bipolar mania. Biol. Psychiatry, 48, 1045–52.Google Scholar

Blumberg, H. P., Leung, H.-C., Skudlarski, P., et al. (2003a). A functional magnetic resonance imaging study of bipolar disorder. Arch. Gen. Psychiatry, 60, 601–9.Google Scholar

Blumberg, H. P., Martin, A., Kaufman, J., et al. (2003b). Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am. J. Psychiatry, 160, 1345–7.Google Scholar

Blumer, D. and Zielinski, J. (1988). Pharmacologic treatment of psychiatric disorders associated with epilepsy. J. Epilepsy, 1, 135–50.Google Scholar

Bocchetta, A.Ardau, R., Burrai, C., et al. (1998). Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J. Clin. Psychopharmacol., 18, 384–9.Google Scholar

Bodkin, J. A. and Amsterdam, J. D. (2002). Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am. J. Psychiatry, 159, 1869–75.Google Scholar

Bodkin, J. A., Zornberg, G. L., Lukas, S. E., and Cole, J. C. (1995). Buprenorphine treatment of refractory depression. J. Clin. Psychopharm., 15, 49–57.Google Scholar

Boerlin, H. L., Gitlin, M. J., Zoellner, L. A., and Hammen, C. L. (1998). Bipolar depression and antidepressant-induced mania: a naturalistic study. J. Clin. Psychiatry, 59, 374–9.Google Scholar

Bogner, H. R. and Gallo, J. J. (2004). Are higher rates of depression in women accounted for by differential symptom reporting? Soc. Psychiatry Psychiatr. Epidemiol., 39, 126–32.Google Scholar

Bolwig, T. G. and Rafaelson, O. J. (1972). Salivation in affective disorders. Psychol. Med., 2, 232–8.Google Scholar

Bonanno, G. A. and Kaltman, S. (2001). The varieties of grief experience. Clin. Psychol. Rev., 21, 705–34.Google Scholar

Bondy, B., Kuznik, J., Baghai, T., et al. (2000). Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am. J. Med. Genet., 96, 831–5.Google Scholar

Bonne, O., Krausz, Y., Shapira, B., et al. (1996). Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J. Nucl. Med., 37, 1075–80.Google Scholar

Bonnet, U. (2003). Moclobemide: therapeutic use and clinical studies. CNS Drug Rev., 9, 97–140.Google Scholar

Booker, J. M. and Hellekson, C. J. (1992). Prevalence of seasonal affective disorder in Alaska. Am. J. Psychiatry, 149, 1176–82.Google Scholar

Borbely, A. A., Tobler, I., Loepfe, M., et al. (1984). All-night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Res., 12, 27–33.Google Scholar

Borod, J. (1992). Interhemispheric and intrahemispheric control of emotion: a focus on unilateral brain damage. J. Consult. Clin. Psychol., 60, 339–48.Google Scholar

Bossert, S., Berger, M., Krieg, J. C., et al. (1988). Cortisol response to various stressful situations: relationship to personality variables and coping styles. Neuropsychobiology, 20, 36–42.Google Scholar

Bostwick, J. M. and Chozinski, J. P. (2002). Temporal competency in catatonia. J. Am. Acad. Psychiatry Law, 30, 371–6.Google Scholar

Bostwick, J. M. and Pankratz, V. S. (2000). Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry, 157, 1925–32.Google Scholar

Bottlender, R., Rudolf, D., Strauss, A., and Moller, H. J. (2000). Are low basal serum levels of the thyroid stimulating hormone (TSH) a risk factor for switches into states of expansive syndrome known in Germany as “maniform syndromes” in bipolar I depression? Pharmacopsychiatry, 33, 75–7.Google Scholar

Bourgon, L. N. and Kellner, C. H. (2000). Relapse of depression after ECT: a review. J. ECT, 16, 19–34.CrossRefGoogle Scholar

Bowden, C. (2004). The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers. J. Affect. Disord., 79 (suppl. 1), S9–S14.Google Scholar

Bowden, C. L., Mitchell, P., and Suppes, T. (1999). Lamotrigine in the treatment of bipolar depression. Eur. Neuropsychopharm, 9 (suppl. 4), S113–S117.Google Scholar

Bowden, C. L., Calabrese, J. R., Sachs, G., et al. (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry, 60, 392–400; erratum in Arch. Gen. Psychiatry, 61, 680.Google Scholar

Bowden, C. L., Asnis, G. M., Ginsberg, L. D., et al. (2004). Safety and tolerability of lamotrigine for bipolar disorder. Drug Safety, 27, 173–84.Google Scholar

Bowen, A., Neumann, V., Conner, M., Tennant, A., and Chamberlain, M. A. (1998). Mood disorders following traumatic brain injury: identifying the extent of the problem and the people at risk. Brain Inj., 12, 177–90.Google Scholar

Bower, W. H. and Altschule, D. (1956). Use of progesterone in the treatment of postpartum psychosis. N. Engl. J. Med., 254, 157–60.Google Scholar

Boyer, W. F. and Feighner, J. P. (1994). Clinical significance of early non-response in depressed patients. Depression, 2, 32–5.Google Scholar

Bozikas, V., Petrikis, P., and Karavatos, A. (2001). Urinary retention caused after fluoxetine-risperidone combination. J. Psychopharmacol., 15, 142–3.Google Scholar

Braconnier, A., Coent, R., and Cohen, D. (2003). Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. Child Adolesc. Psychiatry, 42, 22–9.Google Scholar

Bradvik, L. (2002). The occurrence of suicide in severe depression related to the months of the year and the days of the week. Eur. Arch. Psychiatry Clin. Neurosci., 252, 28–32.Google Scholar

Bradvik, L.(2003). Suicide after suicide attempt in severe depression: a long-tem follow-up. Suicide Life-Threat. Behav., 33, 381–8.Google Scholar

Bradwejn, J. and Koszycki, D. (1994). The cholecystokinin hypothesis of anxiety and panic disorder. Ann. N. Y. Acad. Sci., 713, 273–82.Google Scholar

Bradwejn, J., and Koszycki, D.(2001). Cholecystokinin and panic disorder: past and future clinical research strategies. Scand. J. Clin. Lab. Invest., 234 (suppl.), 19–27.Google Scholar

Brady, L. S., Whitfield, H. J., Fox, R. J., Gold, P. W., and Herkenham, M. (1991). Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J. Clin. Invest., 87, 831–7.Google Scholar

Braga, R. J. and Petrides, G. (2005). The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J. ECT, 21, 75–83.Google Scholar

Braslow, J. (1997). Mental Ills and Bodily Cures. Berkeley, CA:University of California Press.

Bräunig, P., Krüger, S., and Shugar, G. (1998). Prevalence and clinical significance of catatonic symptoms in mania. Compr. Psychiatry, 39, 35–46.Google Scholar

Bräunig, P., Krüger, S., and Shugar, G.(1999). Prävalenz und klinische Bedeutung katatoner Symptome bei Manien. [Prevalence and clinical significance of catatonic symptoms in mania.]Fortschr. Neurol. Psychiatr., 67, 306–17.Google Scholar

Breier, A., Charney, D. S., and Heninger, G. R. (1985). The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am. J. Psychiatry, 142, 787–97.Google Scholar

Bremner, J. D. (2003). Long-term effects of childhood abuse on brain and neurobiology. Child Adolesc. Psychiatr. Clin. North Am., 12, 271–92.Google Scholar

Bremner, J. D., Innis, R. B., Salomon, R. M., et al. (1997). Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry, 54, 364–74.Google Scholar

Bremner, J. D., Naraya, M., Anderson, E. R., et al. (2000). Hippocampal volume reduction in major depression. Am. J. Psychiatry, 157, 115–18.Google Scholar

Brenner, I. (1978). Apathetic hyperthyroidism. J. Clin. Psychiatry, 39, 479–80.Google Scholar

Brent, D. A. (2004). Paroxetine and the FDA. Child Adolesc. Psychiatry, 43, 127–8.Google Scholar

Brent, D. A., Perper, J. A., Moritz, G., et al. (1993). The validity of diagnoses obtained through the psychological autopsy procedure in adolescent suicide victims: use of family history. Acta Psychiatr. Scand., 87, 118–22.Google Scholar

Brent, D. A., Perper, J. A., Moritz, G.(1994). Major depression or uncomplicated bereavement? A follow-up of youth exposed to suicide. J. Am. Acad. Child Adolesc. Psychiatry, 33, 231–9.Google Scholar

Brent, D. A., Bridge, J., Johnson, B. A., and Connolly, J. (1996). Suicidal behavior runs in families. Arch. Gen. Psychiatry 53, 1145–52.Google Scholar

Brent, D. A., Baugher, M., Birmaher, B., Kolko, D. J., and Bridge, J. (2000). Compliance with recommendations to remove firearms in families participating in a clinical trial for adolescent depression. J. Am. Acad. Child Adolesc. Psychiatry, 39, 1220–26.Google Scholar

Brent, D. A., Oquendo, M., Birmaher, B., et al. (2002). Familial pathways to early-onset suicide attempts: a high-risk study. Arch. Gen. Psychiatry, 59, 801–7.Google Scholar

Brent, D. A., Oquendo, M., Birmaher, B., et al. (2003). Peripubertal suicide attempts in offspring of suicide attempters with siblings concordant for suicidal behavior. Am. J. Psychiatry, 160, 1486–93.Google Scholar

Bressan, R. A., Chaves, A. C., Pilowsky, L. S., Shirakawa, I., and Mari, J. J. (2003). Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Res., 117, 47–56.Google Scholar

Bright, T. (1586). A Treatise of Melancholie. London:T. Vautrollier.

Bright-Long, L. and Fink, M. (1993). Reversible dementia and affective disorder: The Rip van Winkle Syndrome. Convuls. Ther., 9, 209–16.Google Scholar

Broadley, A. J., Korszun, A., Jones, C. J., and Frenneaux, M. P. (2002). Arterial endothelial function is impaired in treated depression. Heart, 88, 521–3.Google Scholar

Brockington, I. F. and Kumar, R. (1982). Motherhood and Mental Illness. London:Academic Press.

Brockington, I. F., Winokur, G., and Dean, C. (1982). Puerperal psychosis. In Brockington, I. F. and Kumar, R. (eds) Motherhood and Mental Illness, vol. 3. London: Academic Press. pp. 37–69.

Brodaty, H., Luscombe, G., Parker, G.et al. (1997). Increased rate of psychosis and psychomotor change in depression with age. Psychol. Med., 27, 1205–13.Google Scholar

Brodersen, A., Licht, R. W., Vestergaard, P., Olesen, A. V., and Mortensen, P. B. (2000). Sixteen-year mortality in patients with affective disorder commenced on lithium. Br. J. Psychiatry, 176, 429–33.Google Scholar

Brodsky, B. S., Oquendo, M., Ellis, S. P., et al. (2001). The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am. J. Psychiatry, 158, 1871–77.Google Scholar

Brody, A. L., Saxena, S., Silverman, D. H. S., et al. (1999). Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res., 91, 127–39.Google Scholar

Brody, A. L., Barsom, M. W., Bota, R. G., and Saxena, S. (2001a). Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin. Clin. Neuropsychiatry, 6, 102–12.Google Scholar

Brody, A. L., Saxena, S., Mandelkern, M. A., et al. (2001b). Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry, 50, 171–8.Google Scholar

Brody, A. L., Saxena, S., Stoessel, P., et al. (2001c). Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy. Arch. Gen. Psychiatry, 58, 631–40.Google Scholar

Bromet, E. J., Dunn, L. O., Connell, M. M., Dew, M. A., and Schulberg, H. C. (1986). Long-term reliability of diagnosing lifetime major depression in a community sample. Arch. Gen. Psychiatry, 43, 435–40.Google Scholar

Brook, D. W., Brook, J. S., Zhang, C., Cohen, P., and Whiteman, M. (2002). Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch. Gen. Psychiatry, 59, 1039–44.Google Scholar

Brown, G. W. and Harris, T. (1978). Social Origins of Depression. New York: Free Press.

Brown, W. A. (1990). What happened to the DST? Curr. Contents S&BS, 22, 12–13.Google Scholar

Brown, W. A., and Shuey, I. (1980). Response to dexamethasone and subtype of depression. Arch. Gen. Psychiatry, 37, 747–51.Google Scholar

Brown, W. A., Johnston, R., and Mayfield, D. (1979). The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am. J. Psychiatry, 136, 543–7.Google Scholar

Brown, R. P., Mason, B., Stoll, P., et al. (1986). Adrenocortical function and suicidal behavior in depressive disorders. Psychiatry Res., 17, 317–23.Google Scholar

Brown, G. K., Beck, A. T., Steer, R. A., and Grisham, J. R. (2000). Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J. Consult. Clin. Psychol., 68, 371–7.Google Scholar

Brown, G. W. and Moran, P. (1994). Clinical and psychosocial origins of chronic depressive episodes I: a community survey. Br. J. Psychiatry, 165, 447–56.Google Scholar

Brown, R. P., Stoll, P. M., Stokes, P. E., et al. (1988). Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res., 23, 167–78.Google Scholar